United States · FDA National Drug Code directory
Duobrii
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0187-0653_dbee276a-6a2e-4565-a106-09a5bcca8778
- Product NDC
- 0187-0653
- Form
- LOTION
- Composition / generic term
- halobetasol propionate and tazarotene
- Labeler
- Bausch Health US, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190425
- Source listing expiry
- 20261231
Source-listed ingredients
- HALOBETASOL PROPIONATE — .1 mg/g
- TAZAROTENE — .45 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TUBE in 1 CARTON (0187-0653-01) / 100 g in 1 TUBE · 0187-0653-01
- 6 TUBE in 1 CARTON (0187-0653-03) / 3 g in 1 TUBE · 0187-0653-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →